Navigation Links
Renovis Reports Third Quarter 2007 Financial Results
Date:11/6/2007

tations and estimates. We may not actually achieve these plans, intentions or expectations and Renovis cautions investors not to place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. Various important factors that could cause actual results or events to differ materially from these forward-looking statements include, but are not limited to, the risk that the conditions relating to the required regulatory clearance of the transaction might not be satisfied in a timely manner or at all, risks relating to the integration of the technologies and businesses of Evotec and Renovis, unanticipated expenditures, changing relationships with customers, suppliers and strategic partners, and other factors that are described in greater detail in the reports we file with the Securities and Exchange Commission, including the "Risk Factors" section of our Quarterly Report on Form 10-Q, which was filed with the Securities and Exchange Commission on August 8, 2007, and our Annual Report on Form 10-K, which was filed on March 15, 2007. Renovis is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements as a result of new information, future events or otherwise.

Additional information about the transaction

Renovis filed a Current Report on Form 8-K with the Securities and Exchange Commission on September 24, 2007, that includes as an exhibit the Agreement and Plan of Merger between Evotec and Renovis. Evotec intends to file a Registration Statement on Form F-4 with the Securities and Exchange Commission in connection with the proposed merger. Evotec and Renovis expect to mail a joint proxy statement/prospectus, which will form part of the Registration Statement on Form F-4, to stockholders of Renovis in connection with the proposed merger. This d
'/>"/>

SOURCE Renovis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Renovis to Present at CIBC World Markets Healthcare Conference
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... in Iraq and Afghanistan, more than 300,000 soldiers have ... caused by exposure to bomb blasts and in ... of traumatic brain injury can range from the mild, ... impairments in memory and cognition. , Since 2007, ... importance and complexity of this problem, and has made ...
(Date:9/29/2014)... food security, emerging diseases and biodiversity loss requires ... in Science Express that was co-authored ... College of Agriculture and Life Sciences. , For ... scientists has reviewed progress in addressing a broad ... management using approaches that consider evolutionary histories and ...
(Date:9/29/2014)... (PRWEB) September 29, 2014 Transparency Market ... Synthesis - SPPS, LPPS, HPPS, by Application - Cancer, ... & Generic and by Delivery) - Global Industry Analysis, ... states that the global peptide therapeutics market was worth ... US$25.4 billion by 2018 at an 8.7% CAGR. , ...
(Date:9/29/2014)... , Sept. 29, 2014 /PRNewswire/ - SQI Diagnostics Inc. ... develops and commercializes proprietary technologies and products for advanced ... Peter Winkley to Chairman of the Board ... Mr. Ricks will continue to serve as a Director ... to the Company.  "We are very ...
Breaking Biology Technology:Modeling shockwaves through the brain 2Modeling shockwaves through the brain 3Modeling shockwaves through the brain 4Evolutionary biology: It's not just for textbooks anymore 2Evolutionary biology: It's not just for textbooks anymore 3Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 2Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 3SQI Diagnostics Announces New Chairman of Board of Directors 2
... by hiring laboratory reagent and diagnostics industry veteran , ... ... Inc., a high-tech provider of rapid prototyping and manufacturing services ... President of Operations. Dr. Anderson brings years of entrepreneurial and ...
... for November 6, 2008 at 10:00 a.m. EST, EAST ... ) today reported financial results for,the three and nine months ... of 2008 was $18.2 million or $0.34 per basic and ... net loss of $14.6,million or $0.28 per basic and diluted ...
... announced today the,submission of the response to the ... in Single Dose Containers). In an,Approvable Letter received ... with respect to chemistry, manufacturing, and controls (CMC)., ... complete response as a Class 2,resubmission, under which ...
Cached Biology Technology:ALine, Inc. Expands Management, Adding Roger Anderson, Ph.D., as VP of Operations 2Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 2Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 3Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 4Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 5Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 6Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 7Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 8Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 9Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results 10SALVAT Announces Submission of Complete Response to FDA Approvable Letter for CETRAXAL(R) 2
(Date:9/29/2014)... 2014 Growing Demand From ... Increasing Security Concerns Continue to Propel Biometrics Market ... is one of the fastest growing biometrics ... systems, majorly in various government projects such as ... based biometrics dominates the country,s biometrics market, with ...
(Date:9/29/2014)... release is available in French . ... - The number of days an expectant mother was ... the epigenetic profile of her child, a new study ... and McGill University have detected a distinctive ,signature, in ... the massive Quebec ice storm. Five months after the ...
(Date:9/28/2014)... at the University of California, Santa Cruz, suggest that ... genomes of primates drove the evolution of complex regulatory ... cell of our bodies. , The arms race ... "jumping genes") and the genes that have evolved to ... the first time, identified genes in humans that make ...
Breaking Biology News(10 mins):India Biometrics Market to Surpass USD2.7 Billion by 2019, Finds TechSci Research Study 2India Biometrics Market to Surpass USD2.7 Billion by 2019, Finds TechSci Research Study 3Human genome was shaped by an evolutionary arms race with itself 2Human genome was shaped by an evolutionary arms race with itself 3Human genome was shaped by an evolutionary arms race with itself 4
... to combat osteoporosis and other human common diseases is ... project "BlueGenics" which has received funding of EUR 6 ... team, coordinated by Professor Dr. Werner E.G. Mller from ... Medical Center, intends to identify and to utilize genetic ...
... believe that this knowledge may be important for the ... health issues, that modern science still hasn,t been able ... Center for Infectious Medicine at Karolinska Institutet and the ... time, it,s important to emphasize that humans have lived ...
... 2012 More than 100 academic institutions and ... initiative: Mathematics of Planet Earth (MPE) 2013. This ... mathematics in tackling global problems, including natural disasters ... sustainability; and pandemics. MPE2013 partners will sponsor workshops, ...
Cached Biology News:Launch of the EU large-scale integrating project 'BlueGenics' to combat osteoporosis 2Launch of the EU large-scale integrating project 'BlueGenics' to combat osteoporosis 3How the common 'cat parasite' gets into the brain 2Mathematicians tackle global issues 2Mathematicians tackle global issues 3
... stain kits are optimized for use ... Dodeca stainers. This silver stain kit ... in polyacrylamide gels and are mass ... concentrate, silver reagent concentrate, background reducer ...
... This PTC-100 thermal cycler holds 96 x ... Hot Bonnet heated lid incorporates a thumbwheel ... seal PCR vessels for oil-free cycling. Peltier ... NIST-traceable calibration and ramping rates of up ...
BioGenex IHC Kits for Rodent Tissues are designed for immunohistochemistry on rodent and rabbit tissues that are closely related to the source of the primary antibody. This kit comes with rat seconda...
EZ-DeWax is a one-step solution that simultanously removes paraffin from and rehydrates formalin-fixed, paraffin embedded tissue...
Biology Products: